Guangdong Kanghua Healthcare Group Co (FRA:E9Q) Valuation Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:E9Q Guangdong Kanghua Healthcare Group Co Ltd FRA:E9Q
85 GF Score
Price €0.17
GF Value €0.20
! 1 Warning Sign
View Full Analysis

What is Guangdong Kanghua Healthcare Group Co Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Guangdong Kanghua Healthcare Group Co Valuation Rank Related Terms

FRA:E9Q
85GF Score
Guangdong Kanghua Healthcare Group Co Ltd FRA:E9Q
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Guangdong Kanghua Healthcare Group Co (FRA:E9Q) Overvalued in 2026?

Based on GuruFocus' analysis, Guangdong Kanghua Healthcare Group Co stock appears to be undervalued. The current stock price of €0.17 is trading 13% below its estimated GF Value™ of €0.20.

Key valuation signals for FRA:E9Q:

  • Valuation Rank:
  • GF Value™: €0.20 vs. price of €0.17 (13% below fair value)
  • GF Score™: 85/100 with 1 warning sign

No single metric tells the full story. See the FRA:E9Q stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Guangdong Kanghua Healthcare Group Co Business Description

Other Exchanges 03689:Hong Kong
Address 1000 Dongguan Avenue, Guangdong Province, Dongguan, CHN
Guangdong Kanghua Healthcare Group Co Ltd provides healthcare services. The reportable segments are as follows, The Hospital services segment, which generates majority revenue, includes the provision of hospital services including inpatient healthcare services, outpatient healthcare services, and physical examination services; Rehabilitation and other healthcare services including the provision of rehabilitation services; Elderly healthcare services include the provision of elderly healthcare services, including assisted living, adult daycare, longterm care, residential care and hospice care to the aged patients; and Haemodialysis services segment is principally engaged in the operation of haemodialysis outpatient centres. It generates all of its revenue from the PRC.
85GF Score

Get the complete analysis for FRA:E9Q

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.17
Price
€0.20
GF Value